AXMP Stock Overview
AXM Pharma, Inc. manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
AXM Pharma, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 9,900.00% |
| 1 Year Change | n/a |
| 3 Year Change | -80.00% |
| 5 Year Change | -80.00% |
| Change since IPO | -99.49% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| AXMP | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | 0.08% | 1.2% |
| 1Y | n/a | 13.2% | 24.9% |
Return vs Industry: Insufficient data to determine how AXMP performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how AXMP performed against the US Market.
Price Volatility
| AXMP volatility | |
|---|---|
| AXMP Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.8% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: AXMP's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine AXMP's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | www.axmpharma.net |
AXM Pharma, Inc. manufactures and sells over-the-counter and prescription pharmaceutical products in the People's Republic of China. The company is based in New York, New York.
AXM Pharma, Inc. Fundamentals Summary
| AXMP fundamental statistics | |
|---|---|
| Market cap | US$1.04m |
| Earnings (TTM) | US$8.35m |
| Revenue (TTM) | US$110.68m |
0.0x
P/E Ratio0.0x
P/S RatioIs AXMP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AXMP income statement (TTM) | |
|---|---|
| Revenue | US$110.68m |
| Cost of Revenue | US$89.91m |
| Gross Profit | US$20.77m |
| Other Expenses | US$12.42m |
| Earnings | US$8.35m |
Last Reported Earnings
Jun 30, 2018
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did AXMP perform over the long term?
See historical performance and comparison